UNI HEALTH (02211) announced its interim results for the six months ended December 31, 2025. The group recorded revenue of 267 million yuan, a decrease of 39.5% compared to the same period last year. The loss for the period was 6.1 million yuan, narrowing by 20.78% year-on-year. The basic loss per share was 6.21 fen. According to the announcement, the reduction in the loss attributable to the company's owners was primarily due to the impact of adjustments to China's medical insurance policies and intense market competition, which led to a further decline in revenue. However, this was partially offset by a decrease in sales and marketing expenses during the period.